世界のアシネトバクター肺炎治療薬市場は、2023年に約3億0081万米ドルと評価され、2024年から2032年の予測期間にわたって6.40%を超える健全な成長率で成長すると予想されています。
アシネトバクター肺炎治療薬には、複数の抗生物質に対する耐性で知られるグラム陰性細菌であるアシネトバクター・バウマニによって引き起こされる肺炎を管理するための薬理学的介入と治療法が含まれます。治療アプローチには通常、感染株の感受性プロファイルと関連する合併症に対処するための支持療法を考慮した抗菌剤の組み合わせが含まれます。世界のアシネトバクター肺炎治療薬市場では、ゲノミクスと分子診断の進歩により、アシネトバクター肺炎の治療に精密医療アプローチを実装できるようになりました。感染株の遺伝子プロファイルに基づく個別化された治療戦略により、治療結果が向上し、耐性発現のリスクが最小限に抑えられる可能性があります。
アシネトバクター肺炎の発生率の上昇は、医療関連感染症および多剤耐性との関連性と相まって、世界的な健康対策の重要性に対する認識を高めています。さらに、予防医療への重点の高まりは、世界のアシネトバクター肺炎治療薬市場の発展にとって極めて重要な触媒として浮上しています。治療介入よりも予防措置が優先するという認識が高まるにつれ、この病気の発症を防ぐための戦略に対する需要が高まっています。アシネトバクター肺炎治療薬の規制傾向は、特に新しい抗生物質の開発においてますます厳しくなっています。課題には、急速な抗菌薬耐性の出現、遺伝的耐性メカニズムの検出の限界、肺組織への薬剤浸透の難しさなどがあります。抗生物質の選択肢が限られている中で、ペプチドやナノ粒子などの代替戦略が重要であり、抗菌薬耐性に対するイノベーションの必要性が強調され、アシネトバクター肺炎治療薬市場に課題をもたらしています。
世界のアシネトバクター肺炎治療薬市場調査で検討されている主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。2023年には、北アメリカ米が最大の地域市場でした。この地域は、堅牢な医療システム、厳格な規制プロトコル、意識の高まり、広範な研究イニシアチブの恩恵を受けています。さらに、地理的なアクセスのしやすさと患者人口の集中により、リーダーシップの地位がさらに強化されています。アメリカやカナダなどの国では、アシネトバクター菌による肺炎の症例が急増しており、新しい治療法の広範な研究努力が刺激されています。さらに、政府の支援政策により、製薬メーカーは革新的な医薬品を発売しやすくなりました。この地域の医療費の増大により、肺炎患者に対する診断検査や治療への費用対効果の高いアクセスが容易になり、この地域のアシネトバクター肺炎の治療の進歩を促進する上で重要な役割を果たしています。一方、アジア太平洋地域は、世界市場で最も速い成長を記録すると予想されています。
目次
Table of Contents
Chapter 1.Global Acinetobacter Pneumonia Therapeutics Market Definition and Research Assumptions
1.1.Research Objective
1.2.Market Definition
1.3.Research Assumptions
1.3.1.Inclusion & Exclusion
1.3.2.Limitations
1.3.3.Supply Side Analysis
1.3.3.1.Availability
1.3.3.2.Infrastructure
1.3.3.3.Regulatory Environment
1.3.3.4.Market Competition
1.3.3.5.Economic Viability (Consumer's Perspective)
1.3.4.Demand Side Analysis
1.3.4.1.Regulatory frameworks
1.3.4.2.Technological Advancements
1.3.4.3.Environmental Considerations
1.3.4.4.Consumer Awareness & Acceptance
1.4.Estimation Methodology
1.5.Years Considered for the Study
1.6.Currency Conversion Rates
Chapter 2.Executive Summary
2.1.Global Acinetobacter Pneumonia Therapeutics Market Size & Forecast (2022- 2032)
2.2.Regional Summary
2.3.Segmental Summary
2.3.1.By Drug Class
2.3.2.By Route of Administration
2.4.Key Trends
2.5.Recession Impact
2.6.Analyst Recommendation & Conclusion
Chapter 3.Global Acinetobacter Pneumonia Therapeutics Market Dynamics
3.1.Market Drivers
3.2.Market Challenges
3.3.Market Opportunities
Chapter 4.Global Acinetobacter Pneumonia Therapeutics Market Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter's 5 Force Model
4.1.7.Porter's 5 Force Impact Analysis
4.2.PESTEL Analysis
4.2.1.Political
4.2.2.Economical
4.2.3.Social
4.2.4.Technological
4.2.5.Environmental
4.2.6.Legal
4.3.Top investment opportunity
4.4.Top winning strategies
4.5.Disruptive Trends
4.6.Industry Expert Perspective
4.7.Analyst Recommendation & Conclusion
Chapter 5.Global Acinetobacter Pneumonia Therapeutics Market Size & Forecasts by Drug Class 2022-2032
5.1.Cephalosporins
5.2.Fluoroquinolone
5.3.Glycylcycline
5.4.Carbapenem
5.5.B-Lactam antibiotics
5.6.Sulbactam
5.7.Aminoglycoside
5.8.Polymyxins
5.9.Tetracycline
5.10.Sulfonamide
5.11.Others
Chapter 6.Global Acinetobacter Pneumonia Therapeutics Market Size & Forecasts by Route of Administration 2022-2032
6.1.Parenteral
6.2.Oral
6.3.Others
Chapter 7.Global Acinetobacter Pneumonia Therapeutics Market Size & Forecasts by Region 2022-2032
7.1.North America Acinetobacter Pneumonia Therapeutics Market
7.1.1.U.S. Acinetobacter Pneumonia Therapeutics Market
7.1.1.1. Drug Class breakdown size & forecasts, 2022-2032
7.1.1.2.Route of Administration breakdown size & forecasts, 2022-2032
7.1.2.Canada Acinetobacter Pneumonia Therapeutics Market
7.2.Europe Acinetobacter Pneumonia Therapeutics Market
7.2.1.U.K. Acinetobacter Pneumonia Therapeutics Market
7.2.2.Germany Acinetobacter Pneumonia Therapeutics Market
7.2.3.France Acinetobacter Pneumonia Therapeutics Market
7.2.4.Spain Acinetobacter Pneumonia Therapeutics Market
7.2.5.Italy Acinetobacter Pneumonia Therapeutics Market
7.2.6.Rest of Europe Acinetobacter Pneumonia Therapeutics Market
7.3.Asia-Pacific Acinetobacter Pneumonia Therapeutics Market
7.3.1.China Acinetobacter Pneumonia Therapeutics Market
7.3.2.India Acinetobacter Pneumonia Therapeutics Market
7.3.3.Japan Acinetobacter Pneumonia Therapeutics Market
7.3.4.Australia Acinetobacter Pneumonia Therapeutics Market
7.3.5.South Korea Acinetobacter Pneumonia Therapeutics Market
7.3.6.Rest of Asia Pacific Acinetobacter Pneumonia Therapeutics Market
7.4.Latin America Acinetobacter Pneumonia Therapeutics Market
7.4.1.Brazil Acinetobacter Pneumonia Therapeutics Market
7.4.2.Mexico Acinetobacter Pneumonia Therapeutics Market
7.4.3.Rest of Latin America Acinetobacter Pneumonia Therapeutics Market
7.5.Middle East & Africa Acinetobacter Pneumonia Therapeutics Market
7.5.1. Saudi Arabia Acinetobacter Pneumonia Therapeutics Market
7.5.2. South Africa Acinetobacter Pneumonia Therapeutics Market
7.5.3.Rest of Middle East & Africa Acinetobacter Pneumonia Therapeutics Market
Chapter 8.Competitive Intelligence
8.1.Key Company SWOT Analysis
8.2.Top Market Strategies
8.3.Company Profiles
8.3.1. Pfizer Inc.
8.3.1.1.Key Information
8.3.1.2.Overview
8.3.1.3.Financial (Subject to Data Availability)
8.3.1.4.Product Summary
8.3.1.5.Market Strategies
8.3.2.Merck & Co., Inc.
8.3.3.GlaxoSmithKline Plc (GSK)
8.3.4.AstraZeneca Plc
8.3.5.Novartis AG
8.3.6.Johnson & Johnson Services Inc.
8.3.7.Sanofi S.A.
8.3.8.Bayer AG
8.3.9.Basilea Pharmaceutical Ltd
8.3.10.AbbVie Inc.
Chapter 9.Research Process
9.1.Research Process
9.1.1.Data Mining
9.1.2.Analysis
9.1.3.Market Estimation
9.1.4.Validation
9.1.5.Publishing
9.2.Research Attributes
LIST OF TABLES
TABLE 1.Global Acinetobacter Pneumonia Therapeutics market, report scope
TABLE 2.Global Acinetobacter Pneumonia Therapeutics market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3.Global Acinetobacter Pneumonia Therapeutics market estimates & forecasts by Drug Class 2022-2032 (USD Million)
TABLE 4.Global Acinetobacter Pneumonia Therapeutics market estimates & forecasts by Route of Administration 2022-2032 (USD Million)
TABLE 5.Global Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6.Global Acinetobacter Pneumonia Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7.Global Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8.Global Acinetobacter Pneumonia Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9.Global Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10.Global Acinetobacter Pneumonia Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11.Global Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12.Global Acinetobacter Pneumonia Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13.Global Acinetobacter Pneumonia Therapeutics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14.Global Acinetobacter Pneumonia Therapeutics market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15.U.S. Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 16.U.S. Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17.U.S. Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18.Canada Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 19.Canada Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20.Canada Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21.UK Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 22.UK Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 23.UK Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24.Germany Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 25.Germany Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 26.Germany Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27.France Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 28.France Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 29.France Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30.Italy Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 31.Italy Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 32.Italy Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 33.Spain Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 34.Spain Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 35.Spain Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 36.RoE Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 37.RoE Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 38.RoE Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 39.China Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 40.China Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 41.China Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 42.India Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 43.India Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 44.India Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 45.Japan Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 46.Japan Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 47.Japan Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 48.Australia Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 49.Australia Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 50.Australia Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 51.South Korea Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 52.South Korea Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 53.South Korea Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 54.
TABLE 55.RoAPAC Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 56.RoAPAC Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 57.RoAPAC Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 58.Brazil Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 59.Brazil Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 60.Brazil Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 61.Mexico Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 62.Mexico Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 63.Mexico Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 64.RoLA Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 65.RoLA Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 66.RoLA Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 67.Saudi Arabia Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 68.Saudi Arabia Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 69.Saudi Arabia Acinetobacter Pneumonia Therapeutics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 70.South Africa Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 71.
TABLE 72.South Africa Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 73.South Africa Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 74.RoMEA Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 75.RoMEA Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 76.RoMEA Acinetobacter Pneumonia Therapeutics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 77.List of secondary sources, used in the study of Global Acinetobacter Pneumonia Therapeutics Market.
TABLE 78.List of primary sources, used in the study of Global Acinetobacter Pneumonia Therapeutics Market.
TABLE 79.Years considered for the study.
TABLE 80.Exchange rates considered.
LIST OF FIGURES
FIG 1.Global Acinetobacter Pneumonia Therapeutics market, research methodology
FIG 2.Global Acinetobacter Pneumonia Therapeutics market, market estimation techniques
FIG 3.Global market size estimates & forecast methods.
FIG 4.Global Acinetobacter Pneumonia Therapeutics market, key trends 2023
FIG 5.Global Acinetobacter Pneumonia Therapeutics market, growth prospects 2022-2032
FIG 6.Global Acinetobacter Pneumonia Therapeutics market, porters 5 force model
FIG 7.Global Acinetobacter Pneumonia Therapeutics market, pestel analysis
FIG 8.Global Acinetobacter Pneumonia Therapeutics market, value chain analysis
FIG 9.Global Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 10.Global Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 11.Global Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 12.Global Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 13.Global Acinetobacter Pneumonia Therapeutics market by segment, 2022 & 2032 (USD Million)
FIG 14.Global Acinetobacter Pneumonia Therapeutics market, regional snapshot 2022 & 2032
FIG 15.North America Acinetobacter Pneumonia Therapeutics market 2022 & 2032 (USD Million)
FIG 16.Europe Acinetobacter Pneumonia Therapeutics market 2022 & 2032 (USD Million)
FIG 17.Asia pacific Acinetobacter Pneumonia Therapeutics market 2022 & 2032 (USD Million)
FIG 18.Latin America Acinetobacter Pneumonia Therapeutics market 2022 & 2032 (USD Million)
FIG 19.Middle East & Africa Acinetobacter Pneumonia Therapeutics market 2022 & 2032 (USD Million)
FIG 20.Global Acinetobacter Pneumonia Therapeutics market, company market share analysis (2023)
